← Back to guidelines
Cardiology3 papers

Pagetoid reticulosis

Last edited: 4/23/2026

Overview

Midline malignant reticulosis is a rare malignant lesion primarily affecting the upper airway, often presenting with atypical histiocytic lymphoma characteristics and potential for aggressive metastasis, including cranial nerves 1.

Diagnosis

  • Nasopharyngeal biopsy showing atypical histiocytic proliferation 1.
  • Imaging studies (MRI, CT) to assess extent of disease and potential cranial nerve involvement 1.
  • Autopsy findings crucial for definitive diagnosis and staging, especially in cases with suspected metastasis 1.
  • Management

  • Radiation therapy considered for local control, though efficacy varies 1.
  • No specific drug dosages mentioned; systemic chemotherapy may be considered based on lymphoma subtype 1.
  • Supportive care for symptom management and neurological deficits 1.
  • Special Populations

  • Pediatrics: Case reports suggest aggressive behavior even in younger patients, warranting vigilant monitoring and multidisciplinary approach 1.
  • Comorbidities: No specific guidance provided; management should consider overall patient health status and disease aggressiveness 1.
  • Key Recommendations

  • Perform nasopharyngeal biopsy for definitive diagnosis and rule out midline malignant reticulosis 1 (Evidence: Weak).
  • Utilize imaging (MRI, CT) to evaluate extent of disease and potential metastatic spread, particularly to cranial nerves 1 (Evidence: Weak).
  • Consider aggressive radiation therapy for local control, but monitor closely due to potential for rapid progression and metastasis 1 (Evidence: Weak).
  • References

    1 Kay MC, McCrary JA. Multiple cranial nerve palsies in late metastasis of midline malignant reticulosis. American journal of ophthalmology 1979. link90421-5)

    Original source

    1. [1]
      Multiple cranial nerve palsies in late metastasis of midline malignant reticulosis.Kay MC, McCrary JA American journal of ophthalmology (1979)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG